Barclays
RLAY icon

Barclays’s Relay Therapeutics RLAY Stock Holding History

Barclays’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$887K Buy
47,384
+2,117
+5% +$30.7K ﹤0.01% 2855
2026
Q1 		$450K Sell
45,267
-368,876
-89% -$3.3M ﹤0.01% 3250
2025
Q4 		$3.5M Sell
414,143
-47,736
-10% -$341K ﹤0.01% 2501
2025
Q3 		$2.41M Sell
461,879
-94,643
-17% -$361K ﹤0.01% 2754
2025
Q2 		$1.93M Buy
556,522
+87,351
+19% +$260K ﹤0.01% 2879
2025
Q1 		$1.23M Buy
469,171
+155,969
+50% +$611K ﹤0.01% 2977
2024
Q4 		$1.29M Buy
313,202
+61,383
+24% +$334K ﹤0.01% 3204
2024
Q3 		$1.78M Buy
251,819
+136,541
+118% +$1.02M ﹤0.01% 2945
2024
Q2 		$752K Sell
115,278
-24,718
-18% -$169K ﹤0.01% 2774
2024
Q1 		$1.16M Sell
139,996
-154,789
-53% -$1.51M ﹤0.01% 2995
2023
Q4 		$3.25M Buy
294,785
+79,316
+37% +$669K ﹤0.01% 2493
2023
Q3 		$1.81M Sell
215,469
-93,710
-30% -$1.01M ﹤0.01% 1958
2023
Q2 		$3.88M Buy
309,179
+114,709
+59% +$1.43M ﹤0.01% 1488
2023
Q1 		$3.2M Sell
194,470
-77,369
-28% -$1.39M ﹤0.01% 1849
2022
Q4 		$4.06M Buy
271,839
+121,628
+81% +$2.33M ﹤0.01% 1769
2022
Q3 		$3.36M Buy
150,211
+80,404
+115% +$1.76M ﹤0.01% 1403
2022
Q2 		$1.17M Sell
69,807
-6,261
-8% -$134K ﹤0.01% 2225
2022
Q1 		$2.28M Buy
+76,068
New +$1.85M ﹤0.01% 1771

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Barclays's RLAY Position: Q2 2026 in Review

Barclays increased its Relay Therapeutics (RLAY) stake by 4.7% in Q2 2026, buying an estimated $30.7K and bringing the position to 47,384 shares worth $887K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

Barclays first reported a position in RLAY in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.06M in Q4 2022. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Barclays held 47,384 shares of Relay Therapeutics worth $887K as of Q2 2026.
  • Barclays bought 2,117 Relay Therapeutics shares in Q2 2026, an estimated $30.7K.
  • Relay Therapeutics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2855 holding.
  • Barclays first reported a position in Relay Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Relay Therapeutics position peaked at $4.06M in Q4 2022.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.